RemSleep Holdings (RMSL) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 10.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.71% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 17.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.47% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 13.19% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.97% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9.80% |
| 10 | RemSleep Holdings | - | - | -7,636.00 | -34.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -34.74% |
| Sep 30, 2025 | -20.67% |
| Jun 30, 2025 | -19.46% |
| Mar 31, 2025 | -15.28% |
| Dec 31, 2024 | -11.10% |
| Sep 30, 2024 | 4.90% |
| Jun 30, 2024 | 14.33% |
| Mar 31, 2024 | 15.65% |
| Dec 31, 2023 | 24.16% |
| Sep 30, 2023 | 24.82% |
| Jun 30, 2023 | 24.55% |
| Mar 31, 2023 | 33.09% |
| Dec 31, 2022 | 8.57% |
| Sep 30, 2022 | 11.32% |
| Jun 30, 2022 | 22.16% |
| Mar 31, 2022 | 22.62% |
| Dec 31, 2021 | 39.82% |
| Sep 30, 2021 | 42.02% |
| Jun 30, 2021 | 82.88% |
| Mar 31, 2021 | 132.51% |
| Dec 31, 2020 | 123.99% |
| Sep 30, 2020 | 128.95% |
| Jun 30, 2020 | 109.08% |
| Mar 31, 2020 | 102.14% |
| Dec 31, 2019 | 103.23% |
| Sep 30, 2019 | 77.97% |
| Jun 30, 2019 | 67.54% |
| Mar 31, 2019 | 65.66% |
| Dec 31, 2018 | 40.83% |
| Sep 30, 2018 | 32.21% |
| Jun 30, 2018 | -0.80% |
| Mar 31, 2018 | -17.98% |
| Dec 31, 2017 | 25.01% |